Author

M.K. DeMeo

Observed names: DeMeo, M.K., M. Demeo, M.K. Demeo, Marisa DeMeo

Observed institutions: Hôpital Saint Joseph, Dana-Farber Cancer Institute

OpenAlex ID: A5113426726

Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022

2024 · R.A. Freedman, H.M. Heiling, et al. · Annals of Oncology · 24

Hypomethylation and Hypoexpression of Human CYP2E1 Gene in Lung Tumors

1994 · F. Botto, E. Seree, et al. · Biochemical and Biophysical Research Communications · 12

Phase Ib dose-escalation trial of taselisib (GDC-0032) in combination with HER2-directed therapies in patients with advanced HER2+ breast cancer

2024 · A. Grinshpun, S. Ren, et al. · ESMO Open · 9

6P Combined analysis of the HER2DX genomic tool in adjuvant APT and ATEMPT trials

2023 · P. Tarantino, G. Villacampa, et al. · ESMO Open · 4

Local Therapy Outcomes and Toxicity From the ATEMPT Trial (TBCRC 033), a Phase II Randomized Trial of Adjuvant T-DM1 vs. TH in Women With Stage I HER2 Positive Breast Cancer

2021 · J.R. Bellon, N. Tayob, et al. · International Journal of Radiation Oncology*Biology*Physics · 1

PA-527 Whole Genome Sequencing of Circulating Multiple Myeloma Cells with a Novel Clinical Assay Enables Identification of Genetic Alterations Underlying Immunotherapy Resistance

2026 · Bruno Paiva, Peter M. Voorhees, et al. · Clinical Lymphoma Myeloma & Leukemia

Abstract 1067: Whole genome sequencing of multiple myeloma genomes with a novel clinical assay enables identification of genetic alterations underlying immunotherapy resistance

2026 · Bruno Paiva, Peter Voorhees, et al. · Cancer Research

Comprehensive characterization of multiple myeloma genomes from bone marrow or peripheral blood with a novel clinical assay enables identification of resistance mechanisms

2025 · Bruno Paiva, Patricia Greipp, et al. · Blood

Neratinib and Ado-Trastuzumab-Emtansine for Pre-treated and Untreated HER2-positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium Trial 022

2024 · Melisko, M.E., Santa-Maria, C.A., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)

Works count: 9

Citation count: 50

H-index: 4

I10-index: 2